{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:29:43Z","timestamp":1794360583133,"version":"4.9.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GE 2128\/3-1"],"award-info":[{"award-number":["GE 2128\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["HO 2228\/12-1"],"award-info":[{"award-number":["HO 2228\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Despite intensive research since the emergence of SARS-CoV-2, it has remained unclear precisely which components of the early immune response protect against the development of severe COVID-19. Here,\u00a0we perform a comprehensive immunogenetic and virologic analysis of nasopharyngeal and peripheral blood samples obtained during the acute phase of infection with SARS-CoV-2. We find that soluble and transcriptional markers of systemic inflammation peak during the first week after symptom onset and correlate directly with upper airways viral loads (UA-VLs), whereas the contemporaneous frequencies of circulating viral nucleocapsid (NC)-specific CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells correlate inversely with various inflammatory markers and UA-VLs. In addition, we\u00a0show that high frequencies of activated CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cells\u00a0are present in acutely infected nasopharyngeal tissue, many of which express genes encoding various effector molecules, such as cytotoxic proteins and IFN-\u03b3. The presence of\n                    <jats:italic>IFNG<\/jats:italic>\n                    mRNA-expressing CD4\n                    <jats:sup>+<\/jats:sup>\n                    and CD8\n                    <jats:sup>+<\/jats:sup>\n                    \u00a0T cells in the infected epithelium is further linked with common patterns of gene expression among virus-susceptible target cells and better local control of SARS-CoV-2. Collectively, these results identify an immune correlate of protection against SARS-CoV-2, which could inform the development of more effective vaccines to combat the acute and chronic illnesses attributable to COVID-19.\n                  <\/jats:p>","DOI":"10.1038\/s41467-023-38020-8","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T06:03:34Z","timestamp":1684908214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion"],"prefix":"10.1038","volume":"14","author":[{"given":"Tabea M.","family":"Eser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Baranov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Huth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed I. M.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"De\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7057-6935","authenticated-orcid":false,"given":"Kathrin","family":"Held","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4040-650X","authenticated-orcid":false,"given":"Kami","family":"Pekayvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9179-9203","authenticated-orcid":false,"given":"Alexander","family":"Leunig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0776-5885","authenticated-orcid":false,"given":"Leo","family":"Nicolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-5461","authenticated-orcid":false,"given":"Georgios","family":"Pollakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-1719","authenticated-orcid":false,"given":"Marcus","family":"Buggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9416-2737","authenticated-orcid":false,"given":"David A.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Rubio-Acero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Reich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philine","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alissa","family":"Markgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Puchinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemi","family":"Castelletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Olbrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanika","family":"Vanshylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1376-1792","authenticated-orcid":false,"given":"Florian","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Wieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-3312","authenticated-orcid":false,"given":"Jan","family":"Hasenauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Kroidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hoelscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Geldmacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"38020_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"LR Baden","year":"2020","unstructured":"Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New Engl. J. Med. 384, 403\u2013416 (2020).","journal-title":"New Engl. J. Med."},{"key":"38020_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"New Engl. J. Med."},{"key":"38020_CR3","doi-asserted-by":"crossref","unstructured":"Gilbert, P. B. et al. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial. Science 375, 43\u201350 (2022).","DOI":"10.1126\/science.abm3425"},{"key":"38020_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMoa2117608","volume":"386","author":"J Sadoff","year":"2022","unstructured":"Sadoff, J. et al. Final analysis of efficacy and safety of single-dose Ad26.COV2.S. New Engl. J. Med. 386, 847\u2013860 (2022).","journal-title":"New Engl. J. Med."},{"key":"38020_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","volume":"397","author":"M Voysey","year":"2021","unstructured":"Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99\u2013111 (2021).","journal-title":"Lancet"},{"key":"38020_CR6","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","volume":"19","author":"WT Harvey","year":"2021","unstructured":"Harvey, W. T. et al. SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. 19, 409\u2013424 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"38020_CR7","doi-asserted-by":"crossref","unstructured":"Le Bert, N. et al. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J. Exp. Med. 218, e20202617 (2021).","DOI":"10.1084\/jem.20202617"},{"key":"38020_CR8","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.cell.2020.09.038","volume":"183","author":"CR Moderbacher","year":"2020","unstructured":"Moderbacher, C. R. et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 183, 996\u20131012.e19 (2020).","journal-title":"Cell"},{"key":"38020_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cell.2020.08.017","volume":"183","author":"T Sekine","year":"2020","unstructured":"Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158\u2013168.e14 (2020).","journal-title":"Cell"},{"key":"38020_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41590-021-01084-z","volume":"23","author":"Y Peng","year":"2022","unstructured":"Peng, Y. et al. An immunodominant NP105\u2013113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. Nat. Immunol. 23, 50\u201361 (2022).","journal-title":"Nat. Immunol."},{"key":"38020_CR11","doi-asserted-by":"publisher","first-page":"eabg5021","DOI":"10.1126\/sciimmunol.abg5021","volume":"6","author":"S Notarbartolo","year":"2021","unstructured":"Notarbartolo, S. et al. Integrated longitudinal immunophenotypic, transcriptional, and repertoire analyses delineate immune responses in patients with COVID-19. Sci. Immunol. 6, eabg5021 (2021).","journal-title":"Sci. Immunol."},{"key":"38020_CR12","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.immuni.2016.05.006","volume":"44","author":"J Zhao","year":"2016","unstructured":"Zhao, J. et al. Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity 44, 1379\u20131391 (2016).","journal-title":"Immunity"},{"key":"38020_CR13","doi-asserted-by":"crossref","unstructured":"Liu, J. et al. CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques. Sci. Immunol. 7, eabq7647 (2022).","DOI":"10.1126\/sciimmunol.abq7647"},{"key":"38020_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/nm.2612","volume":"18","author":"TM Wilkinson","year":"2012","unstructured":"Wilkinson, T. M. et al. Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat. Med. 18, 274\u2013280 (2012).","journal-title":"Nat. Med."},{"key":"38020_CR15","doi-asserted-by":"crossref","unstructured":"Lim, J. M. E. et al. SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity. J. Exp. Med. 219, e20220780 (2022).","DOI":"10.1084\/jem.20220780"},{"key":"38020_CR16","doi-asserted-by":"publisher","first-page":"eabl9105","DOI":"10.1126\/sciimmunol.abl9105","volume":"6","author":"MML Poon","year":"2021","unstructured":"Poon, M. M. L. et al. SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci. Immunol. 6, eabl9105 (2021).","journal-title":"Sci. Immunol."},{"key":"38020_CR17","doi-asserted-by":"publisher","first-page":"e2118312119","DOI":"10.1073\/pnas.2118312119","volume":"119","author":"B Kingstad-Bakke","year":"2022","unstructured":"Kingstad-Bakke, B. et al. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants. Proc. Natl. Acad. Sci. USA 119, e2118312119 (2022).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"38020_CR18","doi-asserted-by":"publisher","first-page":"e192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"JC Marshall","year":"2020","unstructured":"Marshall, J. C. et al. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect. Dis. 20, e192\u2013e197 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"38020_CR19","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2598-9","volume":"587","author":"J Braun","year":"2020","unstructured":"Braun, J. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature 587, 270\u2013274 (2020).","journal-title":"Nature"},{"key":"38020_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.immuni.2021.04.006","volume":"54","author":"KE Lineburg","year":"2021","unstructured":"Lineburg, K. E. et al. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses. Immunity 54, 1055\u20131065.e5 (2021).","journal-title":"Immunity"},{"key":"38020_CR21","doi-asserted-by":"publisher","first-page":"eabk0894","DOI":"10.1126\/sciimmunol.abk0894","volume":"6","author":"J Niessl","year":"2021","unstructured":"Niessl, J. et al. Identification of resident memory CD8+ T cells with functional specificity for SARS-CoV-2 in unexposed oropharyngeal lymphoid tissue. Sci. Immunol. 6, eabk0894 (2021).","journal-title":"Sci. Immunol."},{"key":"38020_CR22","doi-asserted-by":"publisher","first-page":"e1003987","DOI":"10.1371\/journal.pmed.1003987","volume":"19","author":"D Buitrago-Garcia","year":"2022","unstructured":"Buitrago-Garcia, D. et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: update of a living systematic review and meta-analysis. PLoS Med. 19, e1003987 (2022).","journal-title":"PLoS Med."},{"key":"38020_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-022-01814-1","volume":"19","author":"S Montazersaheb","year":"2022","unstructured":"Montazersaheb, S. et al. COVID-19 infection: an overview on cytokine storm and related interventions. Virol. J. 19, 92 (2022).","journal-title":"Virol. J."},{"key":"38020_CR24","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","volume":"184","author":"CG Ziegler","year":"2021","unstructured":"Ziegler, C. G. et al. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell 184, 4713\u20134733.e22 (2021).","journal-title":"Cell"},{"key":"38020_CR25","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41586-021-04345-x","volume":"602","author":"M Yoshida","year":"2022","unstructured":"Yoshida, M. et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature 602, 321\u2013327 (2022).","journal-title":"Nature"},{"key":"38020_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24730-4","volume":"12","author":"DS Fischer","year":"2021","unstructured":"Fischer, D. S. et al. Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through \u2018reverse phenotyping\u2019. Nat. Commun. 12, 4515 (2021).","journal-title":"Nat. Commun."},{"key":"38020_CR27","doi-asserted-by":"publisher","first-page":"e1002337","DOI":"10.1371\/journal.ppat.1002337","volume":"7","author":"EM Feeley","year":"2011","unstructured":"Feeley, E. M. et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 7, e1002337 (2011).","journal-title":"PLoS Pathog"},{"key":"38020_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24817-y","volume":"12","author":"C Prelli Bozzo","year":"2021","unstructured":"Prelli Bozzo, C. et al. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat. Commun. 12, 4584 (2021).","journal-title":"Nat. Commun."},{"key":"38020_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-014-0103-y","volume":"11","author":"K Tartour","year":"2014","unstructured":"Tartour, K. et al. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity. Retrovirology 11, 103 (2014).","journal-title":"Retrovirology"},{"key":"38020_CR30","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1073\/pnas.1320856111","volume":"111","author":"X Zhao","year":"2014","unstructured":"Zhao, X. et al. Interferon induction of IFITM proteins promotes infection by human coronavirus OC43. Proc. Natl. Acad. Sci. USA 111, 6756\u20136761 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"38020_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41586-021-03570-8","volume":"595","author":"TM Delorey","year":"2021","unstructured":"Delorey, T. M. et al. COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. Nature 595, 107\u2013113 (2021).","journal-title":"Nature"},{"key":"38020_CR32","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-020-2588-y","volume":"584","author":"C Lucas","year":"2020","unstructured":"Lucas, C. et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature 584, 463\u2013469 (2020).","journal-title":"Nature"},{"key":"38020_CR33","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045.e9 (2020).","journal-title":"Cell"},{"key":"38020_CR34","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/s41586-021-03475-6","volume":"593","author":"AF Rendeiro","year":"2021","unstructured":"Rendeiro, A. F. et al. The spatial landscape of lung pathology during COVID-19 progression. Nature 593, 564\u2013569 (2021).","journal-title":"Nature"},{"key":"38020_CR35","doi-asserted-by":"crossref","unstructured":"Nelson, C. E. et al. Mild SARS-CoV-2 infection in rhesus macaques is associated with viral control prior to antigen-specific T cell responses in tissues. Sci. Immunol. 7, eabo0535 (2022).","DOI":"10.1101\/2022.01.06.475282"},{"key":"38020_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27674-x","volume":"13","author":"R Kundu","year":"2022","unstructured":"Kundu, R. et al. Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Nat. Commun. 13, 80 (2022).","journal-title":"Nat. Commun."},{"key":"38020_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nm1520","volume":"13","author":"P Kiepiela","year":"2007","unstructured":"Kiepiela, P. et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat. Med. 13, 46\u201353 (2007).","journal-title":"Nat. Med."},{"key":"38020_CR38","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1128\/JVI.01847-06","volume":"81","author":"C Geldmacher","year":"2007","unstructured":"Geldmacher, C. et al. CD8 T-cell recognition of multiple epitopes within specific Gag regions is associated with maintenance of a low steady-state viremia in human immunodeficiency virus type 1-seropositive patients. J. Virol. 81, 2440\u20132448 (2007).","journal-title":"J. Virol."},{"key":"38020_CR39","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.4049\/jimmunol.178.5.2746","volume":"178","author":"JB Sacha","year":"2007","unstructured":"Sacha, J. B. et al. Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression. J. Immunol. 178, 2746\u20132754 (2007).","journal-title":"J. Immunol."},{"key":"38020_CR40","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41586-020-2332-7","volume":"583","author":"D Bojkova","year":"2020","unstructured":"Bojkova, D. et al. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 583, 469\u2013472 (2020).","journal-title":"Nature"},{"key":"38020_CR41","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/nsmb785","volume":"11","author":"JA Briggs","year":"2004","unstructured":"Briggs, J. A. et al. The stoichiometry of Gag protein in HIV-1. Nat. Struct. Mol. Biol. 11, 672\u2013675 (2004).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"38020_CR42","doi-asserted-by":"publisher","first-page":"15812","DOI":"10.1073\/pnas.2634931100","volume":"100","author":"P Zhu","year":"2003","unstructured":"Zhu, P. et al. Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. USA 100, 15812\u201315817 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"38020_CR43","doi-asserted-by":"publisher","first-page":"9217","DOI":"10.1128\/JVI.01069-10","volume":"84","author":"JR Teijaro","year":"2010","unstructured":"Teijaro, J. R., Verhoeven, D., Page, C. A., Turner, D. & Farber, D. L. Memory CD4 T cells direct protective responses to influenza virus in the lungs through helper-independent mechanisms. J. Virol. 84, 9217\u20139226 (2010).","journal-title":"J. Virol."},{"key":"38020_CR44","doi-asserted-by":"publisher","first-page":"100520","DOI":"10.1016\/j.xcrm.2022.100520","volume":"3","author":"H Ishii","year":"2022","unstructured":"Ishii, H. et al. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8+ T cell responses. Cell Rep. Med. 3, 100520 (2022).","journal-title":"Cell Rep. Med."},{"key":"38020_CR45","doi-asserted-by":"crossref","unstructured":"Gazit, S. et al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) naturally acquired immunity versus vaccine-induced immunity, reinfections versus breakthrough infections: a retrospective cohort study. Clin. Infect. Dis. 75, e545\u2013e551 (2022).","DOI":"10.1093\/cid\/ciac262"},{"key":"38020_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.chom.2022.02.003","volume":"30","author":"ED Yu","year":"2022","unstructured":"Yu, E. D. et al. Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status. Cell Host Microbe 30, 388\u2013399.e3 (2022).","journal-title":"Cell Host Microbe"},{"key":"38020_CR47","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1084\/jem.20052116","volume":"203","author":"R Draenert","year":"2006","unstructured":"Draenert, R. et al. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus. J. Exp. Med. 203, 529\u2013539 (2006).","journal-title":"J. Exp. Med."},{"key":"38020_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/01.aids.0000247589.77061.f7","volume":"21","author":"C Geldmacher","year":"2007","unstructured":"Geldmacher, C. et al. In a mixed subtype epidemic, the HIV-1 Gag-specific T-cell response is biased towards the infecting subtype. AIDS 21, 135\u2013143 (2007).","journal-title":"AIDS"},{"key":"38020_CR49","doi-asserted-by":"crossref","unstructured":"Puchinger, K. et al. The interplay of viral loads, clinical presentation, and serological responses in SARS-CoV-2 \u2013 Results from a prospective cohort of outpatient COVID-19 cases. Virology 569, 37\u201343 (2022).","DOI":"10.1016\/j.virol.2022.02.002"},{"key":"38020_CR50","doi-asserted-by":"crossref","unstructured":"Radon, K. et al. From first to second wave: follow-up of the prospective COVID-19 cohort (KoCo19) in Munich (Germany). BMC Infect. Dis. 21, 925 (2021).","DOI":"10.1101\/2021.04.27.21256133"},{"key":"38020_CR51","doi-asserted-by":"crossref","unstructured":"Pritsch, M. et al. Prevalence and risk factors of infection in the representative COVID-19 cohort Munich. Int. J. Environ. Res. Public Health 18, 3572 (2021).","DOI":"10.3390\/ijerph18073572"},{"key":"38020_CR52","doi-asserted-by":"crossref","unstructured":"Crawford, K. H. D. et al. Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays. Viruses 12, 513 (2020).","DOI":"10.3390\/v12050513"},{"key":"38020_CR53","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.chom.2021.04.015","volume":"29","author":"K Vanshylla","year":"2021","unstructured":"Vanshylla, K. et al. Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans. Cell Host Microbe 29, 917\u2013929.e4 (2021).","journal-title":"Cell Host Microbe"},{"key":"38020_CR54","doi-asserted-by":"publisher","first-page":"740933","DOI":"10.3389\/fimmu.2021.740933","volume":"12","author":"CN Muefong","year":"2021","unstructured":"Muefong, C. N. et al. Major neutrophil-derived soluble mediators associate with baseline lung pathology and post-treatment recovery in tuberculosis patients. Front. Immunol. 12, 740933 (2021).","journal-title":"Front. Immunol."},{"key":"38020_CR55","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13059-022-02660-8","volume":"23","author":"A Janjic","year":"2022","unstructured":"Janjic, A. et al. Prime-seq, efficient and powerful bulk RNA sequencing. Genome Biol. 23, 88 (2022).","journal-title":"Genome Biol."},{"key":"38020_CR56","doi-asserted-by":"crossref","unstructured":"Parekh, S., Ziegenhain, C., Vieth, B., Enard, W. & Hellmann, I. zUMIs \u2013 a fast and flexible pipeline to process RNA sequencing data with UMIs. Gigascience 7, giy059 (2018).","DOI":"10.1093\/gigascience\/giy059"},{"key":"38020_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"38020_CR58","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1471-2105-10-161","volume":"10","author":"W Luo","year":"2009","unstructured":"Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D. & Woolf, P. J. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics\u00a010, 161 (2009).","journal-title":"BMC Bioinformatics"},{"key":"38020_CR59","unstructured":"Carlson, M., Falcon, S., Pages, H. & Li, N. org.Hs.eg.db: Genome wide annotation for human. R package version 3.8.2. https:\/\/bioconductor.org\/packages\/release\/data\/annotation\/html\/org.Hs.eg.db.html (2019)."},{"key":"38020_CR60","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573\u20133587.e29 (2021).","journal-title":"Cell"},{"key":"38020_CR61","doi-asserted-by":"crossref","unstructured":"Kuleshov, M. V. et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 44, W90\u2013W97 (2016).","DOI":"10.1093\/nar\/gkw377"},{"key":"38020_CR62","first-page":"12","volume":"5","author":"A Henningsen","year":"2010","unstructured":"Henningsen, A. Estimating censored regression models in R using the censReg package. R Package Vignettes 5, 12 (2010).","journal-title":"R Package Vignettes"},{"key":"38020_CR63","doi-asserted-by":"crossref","unstructured":"Steen, N. M., Byrne, G. D. & Gelbard, E. M. Gaussian quadrature for the integrals \u222b\u221e0 exp(\u2212x2)f(x)dx and \u222bb0 exp(\u2212x2)f(x)dx. Math. Comput. 23, 661\u2013671 (1969).","DOI":"10.2307\/2004395"},{"key":"38020_CR64","unstructured":"Revels, J., Lubin, M. & Papamarkou, T. Forward-mode automatic differentiation in Julia. Preprint at https:\/\/arxiv.org\/abs\/1607.07892 (2016)."},{"key":"38020_CR65","doi-asserted-by":"crossref","unstructured":"McKinney, W. Data structures for statistical computing in Python. Proc. 9th Python Sci. Conf. 445, 56\u201361 (2010).","DOI":"10.25080\/Majora-92bf1922-00a"},{"key":"38020_CR66","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","volume":"585","author":"CR Harris","year":"2020","unstructured":"Harris, C. R. et al. Array programming with NumPy. Nature 585, 357\u2013362 (2020).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38020-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38020-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38020-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T06:05:21Z","timestamp":1684908321000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-38020-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["38020"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-38020-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2222184\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"21 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2952"}}